Cargando…

The Chronic Care for Wet Age Related Macular Degeneration (CHARMED) Study: A Randomized Controlled Trial

BACKGROUND: In real life, outcomes in wet age related macular degeneration (W-AMD) continue to fall behind the results from randomized controlled trials. The aim of this trial was to assess if outcomes can be improved by an intervention in healthcare organization following recommendations of the Chr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markun, Stefan, Dishy, Avraham, Neuner-Jehle, Stefan, Rosemann, Thomas, Frei, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646575/ https://www.ncbi.nlm.nih.gov/pubmed/26569501 http://dx.doi.org/10.1371/journal.pone.0143085

Ejemplares similares

The Concordance of Care for Age Related Macular Degeneration with the Chronic Care Model: A Multi-Centered Cross-Sectional Study
por: Markun, Stefan, et al.
Publicado: (2014)

The chronic care for age-related macular degeneration study (CHARMED): Study protocol for a randomized controlled trial
por: Frei, Anja, et al.
Publicado: (2011)

Shared decision making for men facing prostate cancer treatment: a systematic review of randomized controlled trials
por: Martínez-González, Nahara Anani, et al.
Publicado: (2019)

Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)

The improving care in chronic obstructive lung disease study: CAROL improving processes of care and quality of life of COPD patients in primary care: study protocol for a randomized controlled trial
por: Steurer-Stey, Claudia, et al.
Publicado: (2014)

Efficacy of motivating short interventions for smokers in primary care (COSMOS trial): study protocol for a cluster-RCT
por: Grischott, Thomas, et al.
Publicado: (2019)

Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trial
por: Hasler, Susann, et al.
Publicado: (2015)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
por: Garba, Adinoyi O., et al.
Publicado: (2010)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Improving inappropriate medication and information transfer at hospital discharge: study protocol for a cluster RCT
por: Grischott, Thomas, et al.
Publicado: (2018)

Potentially inappropriate proton-pump inhibitor prescription in the general population: a claims-based retrospective time trend analysis
por: Muheim, Leander, et al.
Publicado: (2021)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)

Hypertension affects the treatment of wet age‐related macular degeneration
por: Wang, Ting, et al.
Publicado: (2021)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis, Nikolaos, et al.
Publicado: (2016)

A Randomized Study of Nutritional Supplementation in Patients with Unilateral Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2021)

Evaluation of circulating miRNAs in wet age-related macular degeneration
por: Ertekin, Sevda, et al.
Publicado: (2014)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles, Sadullah, et al.
Publicado: (2014)

Wide-Field Fluorescein Angiography in Wet Age-Related Macular Degeneration
por: Madhusudhan, Savitha, et al.
Publicado: (2014)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
por: Neffendorf, James E, et al.
Publicado: (2015)

Serum Autoantibodies in Patients with Dry and Wet Age-Related Macular Degeneration
por: Korb, Christina A., et al.
Publicado: (2023)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Medication Review and Enhanced Information Transfer at Discharge of Older Patients with Polypharmacy: a Cluster-Randomized Controlled Trial in Swiss Hospitals
por: Grischott, Thomas, et al.
Publicado: (2022)

Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
por: Mukherjee, Chandoshi, et al.
Publicado: (2015)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
Publicado: (2016)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
por: Ozyurt, Ayhan, et al.
Publicado: (2017)

Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
por: Nowosielska, Agnieszka
Publicado: (2019)

Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment
por: Kandula, Sushma, et al.
Publicado: (2010)

Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
por: Chen, Youxin, et al.
Publicado: (2012)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
por: Suetsugu, Tetsuyuki, et al.
Publicado: (2016)

Plasma metabolomic study in Chinese patients with wet age-related macular degeneration
por: Luo, Dan, et al.
Publicado: (2017)

Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration
por: Chen, Ling, et al.
Publicado: (2020)

Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
por: Delaunay, Kimberley, et al.
Publicado: (2021)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
por: Farvardin, Mohsen, et al.
Publicado: (2022)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin, Laurie, et al.
Publicado: (2015)

Long-term results after limited macular translocation surgery for wet age-related macular degeneration
por: Oshima, Hisaaki, et al.
Publicado: (2017)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
por: Avaylon, Jaycob, et al.
Publicado: (2020)

Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography
por: Wei, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6s39f4244e0nsjr9n9k5blcuv9